Influence of Blockade of the Renin-angiotensin System for Preservation of Cognitive Function, Hormonal Counter-regulatory Response, Symptomatology and Cardiac Repolarisation During Hypoglycaemia in Patients With Type 1 Diabetes.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms HypoRas
Most Recent Events
- 05 Feb 2013 Biomarkers information updated
- 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jun 2011 Planned end date changed from 1 Sep 2012 to 1 May 2013 as reported by ClinicalTrials.gov.